Search Within

Christina Bello

  1. "American Society of Hematology"
Formats
  1. Meeting Abstract (5)
Groups
  1. Bone Marrow Transplant (5)
  2. Center for Hematologic Malignancies (5)
  3. Department of Medicine (5)
  4. Hematologic Malignancies, Division of (5)
  5. Myeloma (5)
  6. Survivorship Research (5)

More Groups

People
  1. Hani Hassoun (5)
  2. Heather Landau (5)
  3. Elizabeth Hoover (3)
  4. Elyn Stubblefield (3)
  5. Alexander Lesokhin (2)
  6. Joanne Chou (2)

More People

Years
  1. 2014 (1)
  2. 2012 (1)
  3. 2011 (1)
  4. 2010 (1)
  5. 2009 (1)
Publications
  1. Blood (5)
Publishers
  1. American Society of Hematology (5)

Results (5)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Increased bone marrow plasma cells at diagnosis predicts overall mortality in AL amyloidosis patients undergoing risk-adapted stem cell transplant
    Meeting Abstract

    Landry, C. A.; Smith, M.; Chou, J. F.; Devlin, S. M.; Hassoun, H.; Bello, C.; Landgren, O.; Giralt, S.; Comenzo, R. L.; Landau, H.
    Blood (2014)

    Fulltext@MSK | Save
  • Risk-adapted melphalan and stem cell transplant for systemic light chain amyloidosis: A single institution experience
    Meeting Abstract

    Landau, H.; Fein, D. E.; Hassoun, H.; Bello, C.; Chou, J. F.; Devlin, S.; Giralt, S.; Comenzo, R. L.
    Blood (2012)

    Fulltext@MSK | Save
  • Urinary excretion of epinephrine and dopamine correlates with efficiency of G-CSF mobilized stem cells in patients with AL amyloidosis
    Meeting Abstract

    Landau, H.; Hassoun, H.; Hoffman, J. E.; Bello, C.; Hoover, E.; Riedel, E.; Frenette, P. S.; Comenzo, R. L.
    Blood (2011)

    Fulltext@MSK | Save
  • Maintained hematologic and organ responses at two years following stem cell transplant in systemic light-chain amyloidosis (AL) using short-course bortezomib and dexamethasone consolidation therapy
    Meeting Abstract

    Landau, H.; Hassoun, H.; Rosenzweig, M. A.; Bello, C.; Hoover, E.; Riedel, E.; Lesokhin, A.; Lendvai, N.; Cohen, A.; Nimer, S.; more...
    Blood (2010)

    Fulltext@MSK | Save
  • Adjuvant bortezomib and dexamethasone following risk-adapted melphalan and stem cell transplant in systemic light-chain amyloidosis (AL): A phase II study
    Meeting Abstract

    Landau, H.; Hassoun, H.; Cohen, A. D.; Lesokhin, A.; Bello, C.; Hoover, E.; Riedel, E. R.; Ciminiello, J.; McCullagh, E.; Nimer, S. D.; more...
    Blood (2009)

    Fulltext@MSK | Save